The Impact of Harvest Center on Quality of Marrows Collected from Unrelated Donors
Authors:
- Ellen M. AremanEAEllen M. Areman
- Emanuel CirenzaECEmanuel Cirenza
- Monica YuMYMonica Yu
- Sarah DickersonSDSarah Dickerson
- Patricia L. KotulaPKPatricia L. Kotula
- Ronald A. SacherRSRonald A. Sacher
- Michele Cottler-FoxMCMichele Cottler-Fox
- 1 January 1994
- journal article
- Published by SAGE Publications in Journal of Hematotherapy
- Vol. 3 (1) , 65-70
Abstract
The total number and distribution of nucleated cells in harvested bone marrow are potentially important determinants of patient outcome following bone marrow transplantation. In order to assess whether marrows collected from predominantly unrelated donors at Georgetown University Medical Center (GUMC) were different in cellular content from marrows collected at harvest centers outside of GUMC, we compared the nucleated cell counts and mononuclear cell subset distribution (CD34, CD3, CD4, CD8, CD19 antigen-positive cell content) of 10 consecutive marrows harvested at GUMC to 10 unrelated donor marrows from outside harvest centers. Significantly higher nucleated cell counts and CD34 antigen-positive cell content and significantly lower CD3 and CD4 antigen-positive T-cell numbers were demonstrated among the marrows harvested at GUMC. These results confirmed significant variability in marrow collection practices between GUMC and 10 different outside harvest centers and suggest that strict adherence to a specific collection procedure, involving small volume marrow aspirations and multiple puncture sites, results in a product with a high number of early hematopoietic progenitor cells and minimal contamination by peripheral blood. These data further suggest the need for careful monitoring of individual unrelated donor marrow collection centers' practices to optimize the quality of the harvested marrow.Keywords
This publication has 10 references indexed in Scilit:
- Experiences of the first 493 unrelated marrow donors in the National Marrow Donor ProgramBlood, 1993
- Immunophenotyping of Pediatric Bone MarrowAnnals of the New York Academy of Sciences, 1993
- Standards of the National Marrow Donor Program. NMDP Standards CommitteeTransfusion, 1993
- MARROW TRANSPLANTATION FROM HLA-MATCHED UNRELATED DONORS FOR TREATMENT OF HEMATOLOGIC MALIGNANCIESTransplantation, 1991
- BONE MARROW TRANSPLANTATION USING UNRELATED DONORS FOR PATIENTS WITH ADVANCED LEUKEMIA OR BONE MARROW FAILURETransplantation, 1990
- Successful Allogeneic Transplantation of T-Cell–Depleted Bone Marrow from Closely HLA-Matched Unrelated DonorsNew England Journal of Medicine, 1990
- Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factorBlood, 1989
- Clinical Cytometry and ImmunophenotypingPathology and Immunopathology Research, 1987
- Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host diseaseBlood, 1986
- Marrow Transplantation for Treatment of Aplastic AnemiaNew England Journal of Medicine, 1977